Orient Biotech's subsidiary has obtained registration certificates for two medical device products
I'm PortAI, I can summarize articles.
Orient Biotech's subsidiary Hangzhou Danwei Biotechnology Co., Ltd. recently obtained registration certificates for two medical device products, namely the 14 types of high-risk HPV nucleic acid detection and 16/18 typing reagent kits, and the combined nucleic acid detection reagent kit for the novel coronavirus and influenza A and B viruses. The registration of these products will enrich the company's product line in the fields of HPV virus detection and respiratory virus detection, helping to expand the domestic market
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments